Chad Reiter Email & Phone Number

Bettendorf, Iowa, United States

Toledo, Ohio Area

Toledo, Ohio Area

Fairborn, Oh

■ Develop research initiatives combining industry, academia, and government stakeholders with the goal of product development and job creation, including FDA approval, to support Warfighter performance.▪ Program Lead for Human Performance and Health Science Center of Excellence based at WSU, part of the Ohio Federal Research Network. ▪ Secured funding ($3.5M) and industry cost-share for research projects with emphasis on job creation.▪ Led briefings of program to Ohio academic, industry, and DoD stakeholders. ■ Investigate new approaches to enhance safety of blood transfusions, hemoglobin-based oxygen carriers, and improve outcomes of wound infections and sepsis with novel biologics with partnerships with an international company.■ Assess human physiological parameters from on-body sensors to enhance Warfighter vigilance.■ Coordinated teammates and drafted research proposals of various human performance or health-related topics of interest to the DoD/VA, such as pain, acupuncture, diabetes, and epigenetics.■ Collaborated across disciplines with UAV researchers to develop rural medicine and healthcare solutions.▪ Collaborate with academia and industry for development of novel medical devices to treat hearing loss or tinnitus, and mobile technologies that enhance telehealth medicine and patient-provider services.▪ Secured Phase I and II STTR funding ($1.1M) to investigate biomarkers in breath related to fatigue and sleep deprivation. Forged partnership and CRADA with NAMRU-D Sleep Lab.Wright State University Clinical Trials Research Alliance▪ Initiate a clinical trials research program investigating pharmacological approaches to reduce acclimatization time to altitude and diseases of physiological hypoxia. Coordinated efforts with Navy Medical Research Unit – Dayton (NAMRU), industry, and WSU.▪ Streamlined collaboration with (NAMRU-D) to improve clinical trial enrollment involving industry for potential human performance studies.

Bethesda, Md

Research Experience:■ Collaborate with regulated industry to identify product development needs for enhancing safety and effectiveness of blood products in the areas of trauma, anemia, hemoglobinopathies, and medical countermeasures.■ Investigate methods to modify hemoglobin-oxygen binding to enhance blood substitute therapy for trauma and effects on sickle-cell RBCs to potentially reduce the RBC lysis and vascular occlusion that occurs in vivo.■ Examine novel blood substitute modifiers on effects of mitochondrial function and safety.■ Investigate molecular mechanisms of iron chelators and their effects on hypoxia-related cell signaling and gene expression.■ Expand laboratory research capabilities and establish new molecular techniques to measure mitochondrial function, oxygen delivery to cells in culture, and gene expression.Review Experience:■ Participate in review of blood products and hemoglobin-based oxygen carriers submitted to the Office of Blood Research and Review in the Center for Biologics Evaluation and Research, FDA.■ Participate in pre-IND meetings regarding regulatory and ethical concerns, clinical trial design, safety of participants for clinical trials involving regulated blood products, and appropriate regulatory roadmaps.■ Delivered reviews of products, engaged industry for clarifications.■ Presented the Commissioner’s Fellowship CBER Research Award Seminar.Certifications and Training/FDA Commissioner’s Fellowship Program:■ Epidemiology (Johns Hopkins Bloomberg School of Public Health)■ Intro to Clinical Trials (Johns Hopkins Bloomberg School of Public Health)■ Management of Drug Discovery (Duke Fuqua School of Business)■ Pharmacology/Toxicology Role in Drug Development (FDA/CDER)Certifications and Training/FDA Center for Biologics Evaluation and Research:■ New Reviewer Training, June 2010.■ Technical Writing for Reviewers, October 2010.■ Regenerative Medicine Approaches to the Treatment of Diabetes, December 2010.

Bethesda, Md

■ Investigation of intracellular signal transduction and transcriptional regulation by epigallocatechin gallate (EGCG; a green tea polyphenol) in endothelial cells relevant to vascular, metabolic, and immune function. The studied signaling cascades include proteins that regulate nitric oxide production, cell survival, vascular contraction, and gene transcription.■ Proficient at molecular biology, cell biology, protein biochemistry, adenovirus production, and immunological techniques. These include immunoblotting, immunocytochemistry, ELISA, transient transfection, tissue culture, and mutagenesis.■ Reviewer for The Journal of Biological Chemistry, The American Journal of Physiology, and American Diabetes Association grant applications.■ Managed and supervised research projects of undergraduate students.

Phd, Physiology

Bs, Biochemistry, Mathematics